WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹213 Cr | ₹179 Cr | ₹174 Cr | ₹174 Cr | ₹182 Cr |
What is the latest Total Non-Current Assets ratio of WANBURY ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹213 Cr |
| Mar2024 | ₹179 Cr |
| Mar2023 | ₹174 Cr |
| Mar2022 | ₹174 Cr |
| Mar2021 | ₹182 Cr |
How is Total Non-Current Assets of WANBURY Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹213 Cr | 19.23 | |
| Mar2024 | ₹179 Cr | 2.74 | |
| Mar2023 | ₹174 Cr | 0.31 | |
| Mar2022 | ₹174 Cr | -4.70 | |
| Mar2021 | ₹182 Cr | - | |
Compare Total Non-Current Assets of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹1,160.4 Cr | -0.6% | 16% | 22.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -0.6% |
16% |
22.2% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses